Patents for A61P 35 - Antineoplastic agents (221,099) |
---|
12/19/1996 | CA2222972A1 Reversible cysteine protease inhibitors |
12/19/1996 | CA2222776A1 Biological agent compositions |
12/19/1996 | CA2222625A1 Treatment and prevention of prostatic disease |
12/19/1996 | CA2222593A1 Use of vitamin d4 derivatives for treating cancer |
12/19/1996 | CA2222591A1 Use of vitamin d4 derivatives for treating skin disorders |
12/19/1996 | CA2222551A1 Tumor associated epitopes |
12/19/1996 | CA2222545A1 Quinazolines and pharmaceutical compositions |
12/19/1996 | CA2222520A1 Oligonucleotides specific for cytokine signal transducer gp130 mrna |
12/19/1996 | CA2222335A1 Cytotoxic macrolides |
12/19/1996 | CA2222247A1 Immunotoxins specific for cd80 and cd86 expressing cells |
12/19/1996 | CA2222231A1 Antibody and antibody fragments for inhibiting the growth of tumors |
12/19/1996 | CA2222224A1 Nucleotide analogues for topical treatment of proliferative disease of the skin |
12/19/1996 | CA2222135A1 Hapten modified tumor cell extract and methods of treating or screening for cancer |
12/19/1996 | CA2221821A1 Endothelial-monocyte activating polypeptide iii |
12/19/1996 | CA2221690A1 Use of methioninase in anti-methionine and anti-homocysteine chemotherapy |
12/19/1996 | CA2221602A1 Essential oligonucleotides of vertebrate telomerase |
12/19/1996 | CA2221146A1 Structurally determined metallo-constructs and applications |
12/19/1996 | CA2219980A1 Method for inhibiting neoplastic disease in mammals |
12/19/1996 | CA2196334A1 Urokinase receptor ligands |
12/18/1996 | EP0748795A2 Substituted benzyloxycarbonyl guanidines as Na+/H+ exchange inhibitors, process for their preparation, their use as medicinal or diagnostic agents as well as medicament containing them |
12/18/1996 | EP0748385A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof |
12/18/1996 | EP0748383A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences |
12/18/1996 | EP0748313A1 Cytokine inhibiting imidazole substituted hydroxamic acid derivatives |
12/18/1996 | EP0748220A1 Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex |
12/18/1996 | EP0748219A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
12/18/1996 | EP0748218A1 Plaster-shaped transdermal system with a tamoxifen derivative |
12/18/1996 | EP0710240B1 Novel antimitotic binary alkaloid derivatives extracted from catharanthus roseus |
12/18/1996 | EP0526608B1 Therapeutic agents for the treatment of multidrug resistance to cancers |
12/18/1996 | EP0526598B1 New pharmacologically active catechol derivatives |
12/18/1996 | CN1138350A CNTF Family antagonists |
12/18/1996 | CN1138335A Compounds with growth hormone releasing properties |
12/18/1996 | CN1138295A A novel tumor suppressor gene |
12/18/1996 | CN1138040A New cyclohexane compounds, process for their preparation and pharmaceutical compositions containing them |
12/18/1996 | CN1138037A Adhesion receptor antagonists |
12/18/1996 | CN1138029A Fluorophenyl sbstd. alkenylc arboxylic acid-guanidine its preparation method, applied as medicine and diagnosis agent and medicine containing the compound |
12/17/1996 | US5585512 Esters of p-hydroxyaniline mustard |
12/17/1996 | US5585511 Platinum complex and malignant tumor treating drug containing the same |
12/17/1996 | US5585499 Drug delivery |
12/17/1996 | US5585486 Peptidic ketones as interleukin-1β-converting enzyme inhibitors |
12/17/1996 | US5585474 DNA encoding protein possessing metastasis-inhibitory activity |
12/17/1996 | US5585467 Cultivating a mycins from fungus strain |
12/17/1996 | US5585382 Anticarcinogenic agents |
12/17/1996 | US5585373 3-(7'-oxo-1'-aza-4'-oxabicyclo[3.2.0]-hept-3'-YL)propionic acid derivative as antitumor agent |
12/17/1996 | US5585368 Skin disorders |
12/17/1996 | US5585359 Inhibitors of farnesyl-protein transferase |
12/17/1996 | US5585356 Matrix metalloproteinase peptides: role in diagnosis and therapy |
12/17/1996 | US5585351 T-cadherin adhesion molecule |
12/17/1996 | US5585097 Aglycosylated immunoglobulin g antibody; preventing renal allograft rejection |
12/17/1996 | US5585096 Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
12/17/1996 | US5585089 Humanized immunoglobulins |
12/12/1996 | WO1996039541A1 Colon specific gene and protein |
12/12/1996 | WO1996039524A1 Methods for enhancement of protective immune responses |
12/12/1996 | WO1996039522A1 Human chemokine beta-11 and human chemokine alpha-1 |
12/12/1996 | WO1996039515A1 Human vascular endothelial growth factor 2 |
12/12/1996 | WO1996039511A2 A C5a-LIKE SEVEN TRANSMEMBRANE RECEPTOR |
12/12/1996 | WO1996039509A1 Fibroblast growth factor 15 |
12/12/1996 | WO1996039497A1 Transforming growth factor alpha hi |
12/12/1996 | WO1996039485A1 Human hepatoma-derived growth factor-2 |
12/12/1996 | WO1996039428A1 Antitumor proteins from rana pipiens oocytes |
12/12/1996 | WO1996039420A1 Human criptin growth factor |
12/12/1996 | WO1996039415A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
12/12/1996 | WO1996039185A1 Treatment and diagnosis of prostate cancer |
12/12/1996 | WO1996039160A1 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides |
12/12/1996 | WO1996039154A1 Oligonucleotides having phosphorothioate linkages of high chiral purity |
12/12/1996 | WO1996039152A1 Use of locally applied dna fragments |
12/12/1996 | WO1996039145A1 Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of her-2 autophosphorylation properties |
12/12/1996 | WO1996039141A1 Methods for minimizing bone loss |
12/12/1996 | WO1996039135A1 Methods of inhibiting melanoma |
12/12/1996 | WO1996034010A3 Inhibitors of farnesyl-protein transferase |
12/12/1996 | WO1996033730A3 Chemokine binding protein and methods of use therefor |
12/12/1996 | WO1996033282A3 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations |
12/12/1996 | WO1996030055A3 Radiolabeled peptides for diagnosis and therapy |
12/12/1996 | DE19525900C1 Liver-specific adenovirus expression vector |
12/12/1996 | CA2223957A1 Transforming growth factor alpha hi |
12/12/1996 | CA2223733A1 Human hepatoma-derived growth factor-2 |
12/12/1996 | CA2223421A1 Methods for enhancement of protective immune responses |
12/12/1996 | CA2223291A1 Treatment and diagnosis of prostate cancer |
12/12/1996 | CA2223174A1 Methods for minimizing bone loss |
12/12/1996 | CA2223157A1 Methods of inhibiting melanoma |
12/12/1996 | CA2223103A1 Oligonucleotides having phosphorothioate linkages of high chiral purity |
12/12/1996 | CA2223038A1 A c5a-like seven transmembrane receptor |
12/12/1996 | CA2222280A1 Human chemokine beta-11 and human chemokine alpha-1 |
12/12/1996 | CA2221795A1 Colon specific gene and protein |
12/12/1996 | CA2217301A1 Fibroblast growth factor 15 |
12/11/1996 | EP0747480A1 Oligonucleotides specific for cytokine signal transducer gp130 mRNA |
12/11/1996 | EP0747389A1 3'-substituted nucleoside derivatives |
12/11/1996 | EP0747386A2 Method and antisense oligonucleotides to Interleukin-6 receptor mRNA for inhibiting cellular proliferation |
12/11/1996 | EP0747385A1 Prodrugs of paclitaxel derivatives |
12/11/1996 | EP0747380A1 Compounds and compositions with nitrogen-containing non-basic side chains |
12/11/1996 | EP0747377A1 Compounds and compositions with nitrogen-containing non-basic side chains |
12/11/1996 | EP0747353A2 Indole derivatives |
12/11/1996 | EP0747347A1 RARy-specific retinobenzoic acid derivatives |
12/11/1996 | EP0747345A2 Ethylamido fluorenes and improved method of making same |
12/11/1996 | EP0747056A2 Methods for minimizing bone loss |
12/11/1996 | EP0747053A2 Methods of inhibiting melanoma |
12/11/1996 | EP0746557A1 Intracellular signalling mediators |
12/11/1996 | EP0746554A1 4-heterocyclyl-substituted quinazoline derivatives, processes for their preparation and their use as anti-cancer agents |
12/11/1996 | EP0746544A1 Novel indole derivatives useful to treat estrogen-related neoplasms and disorders |
12/11/1996 | EP0746337A1 Verotoxin pharmaceutical compositions and medical treatments therewith |
12/11/1996 | EP0746323A1 Inhibitors of phosphoinositide-specific phospholipase c |